Breaking News Instant updates and real-time market news.

PNRA

Panera Bread

$203.55

-1.54 (-0.75%)

, CAKE

Cheesecake Factory

$59.43

-0.45 (-0.75%)

11:36
01/04/17
01/04
11:36
01/04/17
11:36

Analysts say buy Panera, sell Dunkin' amid restaurant ratings shake-up

This morning, Wall Street research firms Jefferies and Oppenheimer updated their ratings for several restaurant names. While Oppenheimer analyst Brian Bittner upgraded Panera Bread (PNRA) to Outperform, a buy-equivalent rating, on its "attractive setup" into 2018, his peer at Jefferies downgraded Dunkin' Brands (DNKN) and Cheesecake Factory (CAKE) to Underperform, the firm's equivalent of a sell rating. BUY BREAD: In a research note commenting on the restaurant sector, Oppenheimer's Bittner upgraded Panera Bread to Outperform from Perform, saying that while strategic investments will keep 2017 earnings growth constrained, the "attractive setup" into 2018 "can no longer be ignored." Profit accretion from delivery and strategic investments will "magnify" while sales payoffs continue to ramp, the analyst told investors. Furthermore, Bittner said he is convinced delivery represents a large sales and profit opportunity, calling Panera "the most aggressive non-pizza player" going after the delivery market with its own build-out. 2018 will be the largest profit accretion year as it laps 2017's startup costs with more mature sales levels, he contended. SELL DONUTS, CHEESECAKE: In a note of his own discussing the restaurant sector, Jefferies analyst Andy Barish noted that fourth quarter same-store sales challenges persisted for the industry and margins will likely be pressured by labor and brand investments. The analyst downgraded Dunkin' Brands to Underperform from Hold, saying he does not believe same-store sales have broken out above 2% and pointing out that international growth has been disappointing. Barish also cut his rating on Cheesecake Factory to Underperform from Hold, citing the 15% post-election rally with no change in fundamentals along with the company's "significant" mall exposure. While Cheesecake Factory remains a high quality casual dining operator, the analyst believes it is subject to multiple compression without "significant" new unit growth opportunities. MOVING TO THE SIDELINES: Additionally, Jefferies' Barish downgraded Wingstop (WING) to Hold from Buy, saying the positives, such as visibility to stronger same-store sales and the company's highly franchised business model, are fully discounted in the stock at current levels. Meanwhile, Oppenheimer's Bittner also cut his rating on Bob Evans (BOBE) to Perform from Outperform, as he sees limited upside to future earnings per share estimates and lacks conviction that same-store sales will soon turn positive. While the analyst understands investors' want for a business split, he does not see major upside from it at this time. PRICE ACTION: In late morning trading, shares of Panera and Wingstop gained about 2% each and Dunkin's Brands' stock was fractionally higher. Meanwhile, shares of Cheesecake Factory were fractionally higher as well and Bob Evans' stock slid slightly.

PNRA

Panera Bread

$203.55

-1.54 (-0.75%)

CAKE

Cheesecake Factory

$59.43

-0.45 (-0.75%)

DNKN

Dunkin' Brands

$52.30

-0.14 (-0.27%)

WING

Wingstop

$29.58

-0.01 (-0.03%)

BOBE

Bob Evans

$52.38

-0.83 (-1.56%)

  • 09

    Jan

  • 09

    Jan

  • 21

    Feb

PNRA Panera Bread
$203.55

-1.54 (-0.75%)

01/04/17
01/04/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BofA Merrill Lynch analyst Bryan Spillane upgraded Constellation Brands (STZ) two notches to Buy from Underperform and raised its price target to $175 from $155 based on expectations solid fundamentals will offset tax/trade policy concerns.2. BofA Merrill Lynch analyst Lisa Lewandowski upgraded Altria Group (MO) to Buy and raised its price target to $75 from $70. Despite a rotation out of defensive/bond proxy assets, Lewandowski is positive on potential U.S. tax policy changes that could materially increase Atria's earnings, the strength of the U.S. economy, possible US iQOS commercialization in 2017, and faster growth from "beer equity income" following Anheuser-Busch's recent moves to deleverage. 3. Oppenheimer analyst Brian Bittner upgraded Panera Bread (PNRA) to Outperform saying the "attractive setup" into 2018 "can no longer be ignored." 4. BofA Merrill Lynch analyst Doug Leggate upgraded Chevron (CVX) to Buy from Neutral and raised its price target to $145 saying it is the best way to play the re-weighting in large cap energy portfolios versus U.S. benchmarks. 5. Goldman Sachs analyst Mark Delaney upgraded ON Semiconductor (ON) to Buy from Neutral, saying product cycles and margin improvement can drive outperformance and annual growth of 29% over the next two years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/17
OPCO
01/04/17
UPGRADE
Target $240
OPCO
Outperform
Panera Bread upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Brian Bittner upgraded Panera Bread to Outperform saying the "attractive setup" into 2018 "can no longer be ignored." Profit accretion from delivery and strategic investments will "magnify while sales payoffs continue to ramp," Bittner tells investors in a research note. He has a $240 price target for Panera shares.
12/22/16
RBCM
12/22/16
NO CHANGE
RBCM
RBC Capital names restaurants poised to benefit most from new policies
Panera Bread (PNRA), Chipotle (CMG), and Texas Roadhouse (TXRH) could benefit the most from new policies poised to be enacted in Washington, DC, according to RBC Capital analyst David Palmer. Specifically, restaurant demand is poised to rise about two percentage points as a result of tax reductions, and the companies' EPS is poised to rise as a result of corporate tax cuts, the analyst stated. He keeps Outperform ratings on Panera and Chipotle and, a Sector Perform rating on Texas Roadhouse.
12/22/16
RBCM
12/22/16
NO CHANGE
RBCM
McDonald's, Panera Bread, Starbucks named top restaurant picks at RBC Capital
RBC Capital analyst David Palmer named McDonald's (MCD), Panera Bread (PNRA) and Starbucks (SBUX) as his top restaurant picks heading into 2017. He thinks that their initiatives should improve their sales by mid-2017, while they could also benefit from improved industry trends and corporate tax changes. He adds that McDonald's could benefit from reduced food deflationary pressures, while all restaurants should be boosted by fiscal stimulus.
CAKE Cheesecake Factory
$59.43

-0.45 (-0.75%)

01/04/17
JEFF
01/04/17
DOWNGRADE
Target $51
JEFF
Underperform
Cheesecake Factory downgraded to Underperform from Hold at Jefferies
Jefferies analyst Andy Barish downgraded Cheesecake Factory to Underperform citing the 15% post-election rally with no change in fundamentals along with the company's "significant" mall exposure. The analyst keeps a $51 price target for the shares.
01/04/17
01/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan analyst Richard Vosser downgraded Novartis (NVS) to Neutral from Overweight saying pressures on the company's business are mounting. The pressure from generic erosion in 2017 "remains high" with an estimated $2.3B of sales expected to be lost to generics, said Vosser, who sees "significant downside" to consensus estimates for Novartis. 2. BofA Merrill Lynch analyst Lisa Lewandowski downgraded Philip Morris (PM) to Neutral from Buy and lowered its price target to $96 from $102 citing concerns from the strong U.S. dollar, less impact from an overhaul in U.S. tax policy versus peers, underperformance in combustible tobacco volumes, increasing heat-not-burn competition, a rotation out of defensive/bond proxy assets, and debt convent constraints. 3. Jefferies analyst Andy Barish downgraded Dunkin' Brands (DNKN) to Underperform from Hold, saying he does not believe the company's same-store-sales have broken out above 2% while its international growth has been disappointing. Barish also downgraded Cheesecake Factory (CAKE) to Underperform, citing the 15% post-election rally with no change in fundamentals along with the company's "significant" mall exposure. 4. Evercore ISI downgraded Intuitive Surgical (ISRG) to Hold from Buy and lowered its price target to $690 from $780, with analyst Vijay Kumar saying he expects 2017 to be one of the most challenging for healthcare in general, with the sector facing issues ranging from ACA repeal to border tax reform to interest expense deductibility. 5. Cowen analyst Helane Becker downgraded a number of airline stocks, including United Continental (UAL), JetBlue (JBLU), Alaska Air (ALK) and American Airlines (AAL), to Market Perform from Outperform based on valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/16
JPMS
12/19/16
NO CHANGE
JPMS
JPMorgan says sell Casual Dining names after recent rally
JPMorgan analyst John Ivankoe believes fundamentals in the Casual Dining space have not improved as much as the current stock prices suggest. He recommends fading the rally across the sector, even the names he rates Overweight. Ivankoe has Neutral ratings on Darden (DRI), Cheesecake Factory (CAKE), Texas Roadhouse (TXRH) and Fogo De Chao (FOGO) and Overweight ratings on Brinker (EAT) and Bloomin' Brands (BLMN). Supply growth in the Casual Dining space is increasing across the industry faster than demand while commodity cost benefits are moderating, Ivankoe tells investors in a research note.
11/16/16
SPHN
11/16/16
DOWNGRADE
SPHN
Equal Weight
Cheesecake Factory downgraded to Equal Weight from Overweight at Stephens
DNKN Dunkin' Brands
$52.30

-0.14 (-0.27%)

12/19/16
BMOC
12/19/16
NO CHANGE
BMOC
Dunkin' Brands could be acquired for $65-$75 per share, says BMO Capital
After Bloomberg reported that JAB Holdings could look to buy Dunkin' Brands, BMO Capital analyst AndrewStrelzik estimates that the company could be acquired for $65-$75 per share, based on JAB's other deals in the sector in recent years. However, he says that he's "uncertain" whether the deal will occur and keeps a Market Perform rating on the shares.
12/15/16
MAXM
12/15/16
NO CHANGE
Target $61
MAXM
Buy
Dunkin' Brands price target raised to $61 from $57 at Maxim
Maxim analyst Stephen Anderson said his recent round of channel checks lead him to believe the launch of Dunkin' Donuts locations inside BJ's clubs is off to a solid start. He also thinks cold brew coffee platform extension can possibly drive comp sales in 2017 and that a reversal in coffee prices should reduce pressure on franchisees to raise menu prices. He raised his price target on Dunkin' shares to $61 from $57 and keeps a Buy rating on the stock.
01/04/17
JEFF
01/04/17
DOWNGRADE
Target $45
JEFF
Underperform
Dunkin' Brands downgraded to Underperform from Hold at Jefferies
Jefferies analyst Andy Barish downgraded Dunkin' Brands to Underperform saying he does not believe the company's same-store-sales have broken out above 2% while its international growth has been disappointing. The analyst keeps a $45 price target for the shares.
WING Wingstop
$29.58

-0.01 (-0.03%)

01/04/17
JEFF
01/04/17
DOWNGRADE
Target $30
JEFF
Hold
Wingstop downgraded to Hold from Buy at Jefferies
Jefferies analyst Andy Barish downgraded Wingstop to Hold saying the positives are fully discounted in the stock at current levels. The analyst has a $30 price target for the shares.
09/07/16
KEYB
09/07/16
INITIATION
Target $36
KEYB
Overweight
Wingstop initiated with an Overweight at KeyBanc
Keybanc analyst David Carlson initiated Wingstop with an Overweight and $36 price target. Carlson said Wingstop is poised to grow annual revenue in the mid-teens with at least high-teens earnings growth over the next several years, driven by mid-teens unit expansion and modest G&A leverage.
09/08/16
09/08/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Underperform, $160 target at Cowen with analyst Jeffrey Osborne saying the company is well positioned for the long term but has a "material amount of execution risk" over the next 12 to 18 months. 2. AutoNation (AN) initiated with a Buy at CL King. 3. Wingstop (WING) initiated with an Overweight at KeyBanc. 4. Vivint Solar (VSLR), Sunrun (RUN), and SolarEdge (SEDG) initiated with an Outperform at JMP Securities with the firm initiated First Solar (FSLR) and SunPower (SPWR) with an Underperform. The firm also initiated Canadian Solar (CSIQ) with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/16
WELS
11/14/16
UPGRADE
WELS
Outperform
Wingstop upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jeff Farmer upgraded Wingstop to Outperform citing the company's accelerating unit development momentum and expectations for market share gains. The company could be in a position to pay a second special dividend as early as the first half of 2018, Farmer tells investors in a research note. He raised his price target range for the shares to $32-$34 from $25-$27.
BOBE Bob Evans
$52.38

-0.83 (-1.56%)

12/06/16
MAXM
12/06/16
NO CHANGE
Target $58
MAXM
Buy
Bob Evans break-up potential rising, says Maxim
Maxim analyst Stephen Anderson attributes the positively reaction to Bob Evans' Q2 results primarily to the fact that company named J.P. Morgan to evaluate potential strategies for value creation, which he take as evidence that management is more serious about a potential separation of the Bob Evans Restaurants and BEF Foods businesses. The analyst, who now sees greater potential for a split that would provide a catalyst for additional upside, has a Buy rating and $58 price target on Bob Evans shares.
01/04/17
OPCO
01/04/17
DOWNGRADE
OPCO
Perform
Bob Evans downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Brian Bittner downgraded Bob Evans to Perform citing the stock's 37% rally in 2016 and limited upside potential to future earnings estimates. The analyst lacks conviction that the company's same-store-sales will soon turn positive.
12/06/16
OPCO
12/06/16
NO CHANGE
Target $55
OPCO
Outperform
Bob Evans price target raised to $55 from $50 at Oppenheimer
Oppenheimer analyst Brian Bittner raised his price target for Bob Evans to $55 from $50 after the company delivered a Q2 EPS beat and "surprisingly" raised 2017 guidance for the second consecutive quarter. The analyst reiterates an Outperform rating on the shares.
05/17/16
05/17/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Intel (INTC) initiated with an Underperform at CLSA. 2. Qualcomm (QCOM) initiated with an Outperform at CLSA. 3. Bob Evans (BOBE) initiated with a Buy at Maxim. 4. Broadcom Limited (AVGO) initiated with an Outperform at CLSA. 5. SecureWorks (SCWX) initiated with a Buy at BofA/Merrill, Goldman, Stifel and SunTrust. It was also initiated with an Outperform at RBC Capital, William Blair, Barclays and JPMorgan. Furthermore, it was initiated with a Neutral at Citi, Credit Suisse and UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/25/17
06/25
04:55
06/25/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/25/17
06/25
04:55
06/25/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

AAPL

Apple

$146.28

0.65 (0.45%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

13:47
06/24/17
06/24
13:47
06/24/17
13:47
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$146.28

0.65 (0.45%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

GOOG

Alphabet

$965.59

8.5 (0.89%)

MSFT

Microsoft

$71.21

0.95 (1.35%)

IBM

IBM

$154.11

-0.29 (-0.19%)

MA

MasterCard

$124.01

0.71 (0.58%)

ORCL

Oracle

$50.95

0.65 (1.29%)

VMW

VMware

$90.92

0.48 (0.53%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AKAM

Akamai

$51.30

1.28 (2.56%)

SAP

SAP

$107.48

0.42 (0.39%)

QCOM

Qualcomm

$56.91

0.44 (0.78%)

ADBE

Adobe

$145.41

1.72 (1.20%)

ACN

Accenture

$122.74

0.66 (0.54%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

CYH

Community Health

$9.33

0.06 (0.65%)

THC

Tenet

$18.52

-0.38 (-2.01%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

UHS

Universal Health

$115.43

0.22 (0.19%)

AET

Aetna

$152.10

-0.88 (-0.58%)

WCG

WellCare

$183.28

-0.32 (-0.17%)

CI

Cigna

$169.61

-1.07 (-0.63%)

HUM

Humana

$238.42

1.42 (0.60%)

ANTM

Anthem

$190.17

-3.19 (-1.65%)

HNT

Health Net

CNC

Centene

$84.15

1.15 (1.39%)

MOH

Molina Healthcare

$71.33

0.02 (0.03%)

UNH

UnitedHealth

$185.25

-1.25 (-0.67%)

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

X

U.S. Steel

$22.25

1.18 (5.60%)

AKS

AK Steel

$6.65

0.35 (5.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 06

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 02

    Aug

  • 14

    Aug

  • 23

    Oct

  • 03

    Feb

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

ANTM

Anthem

$190.17

-3.19 (-1.65%)

18:58
06/23/17
06/23
18:58
06/23/17
18:58
Periodicals
Anthem to pay $115M to settle data breach lawsuits, Reuters reports »

Anthem has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVU

Supervalu

$2.94

-0.04 (-1.34%)

18:26
06/23/17
06/23
18:26
06/23/17
18:26
Hot Stocks
Supervalu completes acquisition of Unified Grocers »

Supervalu announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$70.52

0.04 (0.06%)

18:14
06/23/17
06/23
18:14
06/23/17
18:14
Periodicals
Gilead no longer a 'value trap,' Barron's reports »

Consistent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

, EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

18:07
06/23/17
06/23
18:07
06/23/17
18:07
Hot Stocks
Southern National Bancorp, Eastern Virginia Bankshares complete merger »

Southern National Bancorp…

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$104.84

0.3 (0.29%)

17:56
06/23/17
06/23
17:56
06/23/17
17:56
Hot Stocks
IAC will not pursue plan to create new class of non-voting stock »

IAC's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGL

Engility

$27.37

0.26 (0.96%)

17:50
06/23/17
06/23
17:50
06/23/17
17:50
Hot Stocks
Engility to eliminate position of president, COO »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

ADM

Archer Daniels

$41.16

0.13 (0.32%)

17:48
06/23/17
06/23
17:48
06/23/17
17:48
Hot Stocks
ADM Animal Nutrition recalls Rough-N-Ready cattle feed over monensin concerns »

ADM Animal Nutrition, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$35.24

0.03 (0.09%)

17:30
06/23/17
06/23
17:30
06/23/17
17:30
Syndicate
Breaking Syndicate news story on Voya Financial »

Voya Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

, TBK

Triumph Bancorp

17:19
06/23/17
06/23
17:19
06/23/17
17:19
Hot Stocks
Independent Bank to sell nine Colorado branches to TBK Bank »

Independent Bank (IBTX)…

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

TBK

Triumph Bancorp

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

WUBA

58.com

$43.30

0.87 (2.05%)

17:11
06/23/17
06/23
17:11
06/23/17
17:11
Hot Stocks
Breaking Hot Stocks news story on 58.com »

General Atlantic reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

, LGF.B

Lionsgate

$25.38

0.34 (1.36%)

17:10
06/23/17
06/23
17:10
06/23/17
17:10
Hot Stocks
Box Office Battle: 'Transformers' expected to top 'Cars 3,' 'Wonder Woman' »

Viacom (VIA, VIAB)…

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

LGF.B

Lionsgate

$25.38

0.34 (1.36%)

DIS

Disney

$104.36

0.14 (0.13%)

VIAB

Viacom

$34.11

-0.01 (-0.03%)

LGF.A

Lionsgate

$27.07

0.31 (1.16%)

VIA

Viacom

$39.15

0.1 (0.26%)

SNE

Sony

$38.52

0.11 (0.29%)

FOX

21st Century Fox

$26.93

0.3 (1.13%)

TWX

Time Warner

$99.70

0.3 (0.30%)

CMCSA

Comcast

$39.50

-0.44 (-1.10%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

NVUS

Novus Therapeutics

$6.00

-0.04 (-0.66%)

17:07
06/23/17
06/23
17:07
06/23/17
17:07
Syndicate
Breaking Syndicate news story on Novus Therapeutics  »

Novus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.88

0.03 (3.53%)

17:05
06/23/17
06/23
17:05
06/23/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Interpace Diagnostics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$14.95

0.26 (1.77%)

17:02
06/23/17
06/23
17:02
06/23/17
17:02
Hot Stocks
Monmouth Real Estate acquires building in Texas for $50.6M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

ARCW

ARC Group

$3.55

0.15 (4.41%)

17:01
06/23/17
06/23
17:01
06/23/17
17:01
Hot Stocks
ARC Group names Drew Kelley as Interim CEO, effective July 1 »

ARC Group Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$4.41

-0.08 (-1.78%)

16:55
06/23/17
06/23
16:55
06/23/17
16:55
Syndicate
PAVmed announces effectiveness of Form S-1 resale registration statement »

PAVmed announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFSF

MutualFirst Financial

$36.15

0.9 (2.55%)

16:48
06/23/17
06/23
16:48
06/23/17
16:48
Hot Stocks
MutualFirst Financial senior executives enter 10b5-1 trading plans »

On June 23, David Heeter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.10

0.25 (0.78%)

16:46
06/23/17
06/23
16:46
06/23/17
16:46
Hot Stocks
Cisco CEO Charles Robbins enters 10b5-1 trading plan »

On June 21, Charles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SITO

SITO Mobile

$3.66

0.02 (0.55%)

16:43
06/23/17
06/23
16:43
06/23/17
16:43
Hot Stocks
SITO Mobile chairman Paul Pressler resigns »

Effective as of June 23,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$517.33

-9.2 (-1.75%)

, CELG

Celgene

$134.31

0.63 (0.47%)

16:41
06/23/17
06/23
16:41
06/23/17
16:41
General news
S&P sees mild weekly gain, Nasdaq outperforms as biotech shines »

The S&P finished the…

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

GILD

Gilead

$70.54

0.06 (0.09%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

ABBV

AbbVie

$72.64

-0.54 (-0.74%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BA

Boeing

$202.23

2.79 (1.40%)

ORCL

Oracle

$50.95

0.65 (1.29%)

EQT

EQT Corporation

$56.19

4.16 (8.00%)

RICE

Rice Energy

$25.65

1.62 (6.74%)

SYK

Stryker

$141.12

-0.1 (-0.07%)

NVDQ

Novadaq

$11.78

-0.02 (-0.17%)

PRXL

Parexel

$86.80

-0.31 (-0.36%)

LH

LabCorp

$151.62

1.28 (0.85%)

ICLR

ICON plc

$96.37

-0.26 (-0.27%)

NKE

Nike

$52.85

0.45 (0.86%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AMD

AMD

$14.15

-0.23 (-1.60%)

LZB

La-Z-Boy

$32.30

0.7 (2.22%)

RHT

Red Hat

$99.42

0.54 (0.55%)

AAL

American Airlines

$48.63

-0.34 (-0.69%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

THC

Tenet

$18.52

-0.38 (-2.01%)

SCS

Steelcase

$13.65

-0.45 (-3.19%)

ACN

Accenture

$122.74

0.66 (0.54%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 07

    Jul

  • 13

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 14

    Aug

  • 29

    Aug

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 23

    Oct

  • 14

    Nov

  • 15

    Jan

  • 03

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.